On October 6 at 1:00 p.m., join FDA’s Division of Drug Information in the Center for Drug Evaluation and Research for a webinar on innovative FDA collaborations. In this Category 1 CME-eligible webinar, Teresa Rubio, PharmD, and Ankur Kalola, PharmD, will discuss the FDA’s Bad Ad Program and how health care professionals can report such ads. Specifically, you will learn:
- Ways health care providers can collaborate with the FDA, including effectively reporting misleading prescription drug promotion to the FDA through the Bad Ad Program
- The FDA’s role in regulating prescription drug promotion and advertising
- The role that health care professionals can play in protecting the public health by ensuring that prescription drug promotion and advertising is truthful and not misleading
- How health care professionals can effectively report misleading prescription drug promotion to the FDA through the Bad Ad Program
This webinar is one in a series designed to help health professionals “provide better patient care by knowing how to find relevant FDA regulatory information that will improve drug safety.” To sign up for the webinar, please visit the registration page.